Dexcom (DXCM) Total Current Liabilities (2010 - 2026)

Dexcom (DXCM) has 17 years of Total Current Liabilities data on file, last reported at $2.2 billion in Q1 2026.

• On a quarterly basis, Total Current Liabilities fell 26.78% year-over-year to $2.2 billion in Q1 2026; TTM through Mar 2026 was $2.2 billion, a 26.78% decrease from a year earlier, with the FY2025 full-year figure at $2.1 billion, down 26.93% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $2.2 billion, up from $2.1 billion in the prior quarter.
• Over the last five years, Total Current Liabilities for DXCM reached as high as $3.3 billion in Q3 2025 and fell as low as $711.4 million in Q1 2022.
• Historically, Total Current Liabilities has averaged $2.0 billion across 5 years, with a median of $1.8 billion in 2022.
• Across the five-year window, Total Current Liabilities jumped 162.16% in 2023 and dropped 26.93% in 2025, its largest moves.
• Year by year, Total Current Liabilities stood at $1.8 billion in 2022, then decreased by 15.4% to $1.6 billion in 2023, then jumped by 88.43% to $2.9 billion in 2024, then fell by 26.93% to $2.1 billion in 2025, then advanced by 3.79% to $2.2 billion in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $2.2 billion in Q1 2026, $2.1 billion in Q4 2025, and $3.3 billion in Q3 2025.